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Abstract
Background: Children with attention deficit hyperactivity disorder (ADHD) are hyperactive and impulsive, cannot
maintain attention, and have difficulties with social interactions. Medical treatment may alleviate symptoms of
ADHD, but seldom solves difficulties with social interactions. Social-skills training may benefit ADHD children in
their social interactions. We want to examine the effects of social-skills training on difficulties related to the
children’s ADHD symptoms and social interactions.
Methods/Design: The design is randomised two-armed, parallel group, assessor-blinded trial. Children aged 8-12
years with a diagnosis of ADHD are randomised to social-skills training and parental training plus standard
treatment versus standard treatment alone. A sample size calculation estimated that at least 52 children must be
included to show a 4-point difference in the primary outcome on the Conners 3
rd Edition subscale for
‘hyperactivity-impulsivity’ between the intervention group and the control group. The outcomes will be assessed 3
and 6 months after randomisation. The primary outcome measure is ADHD symptoms. The secondary outcome is
social skills. Tertiary outcomes include the relationship between social skills and symptoms of ADHD, the ability to
form attachment, and parents’ ADHD symptoms.
Discussion: We hope that the results from this trial will show that the social-skills training together with
medication may have a greater general effect on ADHD symptoms and social and emotional competencies than
medication alone.
Trial registration: ClinicalTrials (NCT): NCT00937469
Background
Attention deficit hyperactivity disorder (ADHD) affects
3% to 5% of all children [1]. The main ADHD symp-
toms consist of problems with attention, impulsiveness,
and hyperactivity [2,3]. Pharmacological treatment of
children and adolescents with ADHD has beneficial
effects on these symptoms in about 80% of the patients
[4-12]. However, many children and adolescents with
ADHD also frequently have difficulties regarding
language, learning, anxiety, and interaction with parents
and teachers. These difficulties can be severe, and there
is little evidence that medication has an effect on these
outcome measures [13-17]. Children with ADHD also
have an increased risk of developing personality distur-
bance and possibly psychotic conditions, abuse of drugs
or alcohol, and criminality [18-24]. Comorbid disorders
in children with ADHD often include behavioural disor-
ders, depression, anxiety, tics, motor skill development
disturbance, learning difficulties, and verbal and cogni-
tive difficulties [25,26].
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Social-skills training aims to develop, improve, and
maintain the individual’s social skills. This is achieved
by teaching how to regulate verbal and nonverbal
behaviours involved in social interactions and in com-
pliance with social norms [27,28]. The main elements
in social-skills training include training of social skills
and efforts to change the individual’sc o g n i t i v ea s s e s s -
ment of the ‘social world’ and to develop these cogni-
tive skills (Fohlmann AH: E-mail correspondence in
April 2009). Concretely, the training focuses on teach-
ing the children to read the subtle cues in social inter-
actions, such as learning to wait for their turn or
knowing when to shift topics during a conversation
and being able to recognise the emotional expressions
of others. A few randomised clinical trials suggest that
social-skills training may help children with ADHD
[29-31]. Other studies indicate that only some children
benefit from social-skills training, possibly due to lack
of parental engagement in the training [32]. Like with
medical treatment, the effects of social-skills training
do not always appear to endure over time. It is even
argued that social-skills training groups can have a
negative effect on children with behavioural problems
because the aggressive and restless behaviour in itself
can limit the ability to learn social skills [33]. We have
been unable to identify any meta-analyses or systema-
tic reviews on the topic.
Abilities in forming attachments
Ac h i l d ’s ability to form attachments is developed in
early childhood through interaction with primary care-
givers. Different forms of attachment are secure, inse-
cure dismissing, insecure preoccupied, and disorganised.
It is assumed that these different forms of attachment
will influence the outcome of social-skills training. A
connection between early disorganised attachment and
later ADHD has been demonstrated by Punto et al. [34],
who followed children from birth to 7 years of age.
The primary aim of the SOSTRA trial is to examine
the effect of the combination of social-skills training and
parental training plus standard treatment versus stan-
dard treatment alone in children with ADHD and their
families on the outcome measures of ADHD core symp-
toms, social skills, and the attachment between the child
and the parents.
Methods/Design
Children aged 8-12 years with a diagnosis of ADHD and
their parents are randomised to the combination of
social-skills training and parental training plus standard
treatment versus standard treatment alone. The trial
flowchart is shown in Figure 1. The trial is a randomised
two-armed, parallel group, assessor-blinded trial.
The children will be examined at entry, 3 months, and 6
months after randomisation.
Experimental intervention
Children and parents randomised to the experimental
intervention are included in 1 of 4 identical 8-week
social-skills treatment programs with 12 to 16 partici-
pants per program. Here, the children are offered weekly
social-skills training sessions of 90 minutes in duration.
During that time, the parents attend parental training.
Each group has two therapists who have been trained in
management of social-skills training at Langager School
in Aarhus [35]. The experimental interventions are thor-
oughly described in a manual, and each session with the
children will be video recorded. The group sessions are
planned to be on the same day and at the same time
e v e r yw e e k ,j u s ta st h es t r u c t u r ea n dt h ea g e n d ao ft h e
sessions will be the same. The experimental intervention
program is organized similarly to other randomised
trials [29-31] and with supervision from the Langager
School. Different methods of teaching the children social
skills are used, all of which have proved successful in
other social-skills programs [36]. These include didactic
instructions, work with symbols (e.g. dolls), role-play,
creative techniques, physical exercises, music, story
reading, games, and movies. Each session has a theme,
such as self worth, nonverbal communication, feelings,
impulse control, aggression management, conflict reso-
lution, and problem solving. The themes are connected
to the trials outcome measures of ADHD core symp-
toms, social skills, and the attachment between the child
and the parents.
Social skills are based on the broad area of cognition
and emotions. The iceberg model (Division TEACCH,
North Carolina, USA) emphasizes the importance of
considering each child’s problems and resources dis-
tinctly and incorporating these in the training pro-
gramme. For instance, some children may need more
sessions with visualization techniques to better learn the
management of aggression. When they get better at
managing their aggression, they will also be able to
improve their social skills. The social-skills experimental
intervention will focus on strengthening the ability of
the children to control themselves and start a self-help
process. For the parents, efforts will be directed at help-
ing them develop strategies to assist their children in
controlling their impulses. It is important that this train-
ing equips the children and parents with the skill to
cope better and to reverse the bad circles. The efficacy
of the experimental intervention will be assessed by
improvements in ADHD symptoms and social skills per
se or by assessing psychological functioning on a
broader aspect, including the quality of peer relation-
ships and emotional competencies.
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the group. The children should feel safe enough to play
and experiment with exploring their own and other peo-
ple’s understanding of them along with understanding
the other participants and the different topics in focus.
The assignments must be clear and simple. The educa-
tional style in the groups will take into account the chil-
dren’s special cognitive difficulties; accordingly, the
structure in each session will be predictable. This is
secured by regular items on the agenda, which are
Assessment of patients according to
inclusion- and exclusion criteria (n=)
Inclusion of eligible patients
(n=)
Randomisation (n=)
Baseline: Week 0
Standard
treatment
week 1-8
(e.g. medical
treatment,
parental
group)
Standard
treatment
week 1-8
(e.g. medical
treatment,
parental
group)
Flow Chart figur 4
Outcome assessment 3
months after baseline
Outcome assessment 6
months after baseline
Outcome assessment 3
months after baseline
Outcome assessment 6
months after baseline
Flowchart
CAI interviews
Start medical treatment
Social skills
training 8
weeks
Children
group
Social skills
training 8
weeks
Parents
group
Figure 1 A flow chart of the SOSTRA design.
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Page 3 of 11written on the blackboard every time: Opening round–
what has happened since the last time? — revision of
the previous session; homework from previous session;
presentation/education; role play/creative activities; new
homework; closing round.
The therapists must be clear and direct but not con-
frontational or critical. Weight is attached to empathy,
positive reinforcement, and a curious ‘non-knowing’
mentalizing attitude. A relaxed atmosphere with room
for humour is the aim.
The therapists who are responsible for the children’s
group in the experimental intervention arm are also
responsible for the parents’ group in the standard treat-
ment arm. This risk of bias will be limited by writing
the detailed manual that will describe the content in
each group. Content forms are to be completed by the
therapists after each group sessions and will function as
a control of the content of the sessions given.
In the parental groups, the themes from the children’s
groups will be presented and discussed. Likewise, the
children’s homework will be discussed and parents are
encouraged to discuss their specific problems with their
children and there will be an exchange of experiences
among the participants.
Standard treatment
The standard treatment offered to both the experimen-
tal group and the control group encompasses the nor-
mal practice regarding ADHD patients at the Child
Psychiatric Daytime Clinic in Holbaek. The overall
objective is to secure compliance with the treatment,
which means that the team attaches importance to
building an alliance with the family, creating safety, and
ensuring that the family receives sufficient counselling,
psychological education, and support to enable them to
be more confident and autonomous regarding the pro-
blems and challenges of having a child with an ADHD.
After assessment and confirmation of the ADHD diag-
nosis, the family is offered medical treatment for the
child. The medical protocol is shown in Figure 2. Medi-
cal treatment is always preceded by a physical examina-
tion; the somatic condition of the child is examined and
an individually adapted neurological examination is per-
formed. The physician informs the parents of the advan-
tages and disadvantages of medical treatment. The
family is asked to contact the clinic within a week of
medical treatment initiation to report on the child’s pro-
gress. From this meeting, it is decided whether the
dosage regimen is satisfactory. All children are examined
again after 1 month of treatment; positive and adverse
effects are evaluated and educational counselling is
given. If the child has gained weight, nutrition advice is
given; if the child has developed sleeping problems, a
special duvet can be borrowed or medication can be
prescribed. The standard treatment involves a parent
group where the parents meet three times during the 8-
week trial period. In addition to general information
about ADHD, focus is placed on different aspects
related to the disorder, such as the child’s relationship
with siblings and peers. Talks will be given by visiting
adults who have been diagnosed with ADHD. They talk
to the group about their experiences of living with
ADHD, having children, and making everyday life
function.
Screening and recruitment of participants
The children are those referred to the Child Psychiatric
Clinics in Holbaek and Roskilde with an ADHD diagno-
sis. They are screened according to the inclusion and
exclusion criteria (Table 1). The parents will sign a writ-
ten informed consent in the first meeting in the clinic.
The Schedule for Affective Disorders and Schizophrenia
for School-aged Children (K-SADS) will be used in the
baseline assessment. This semi-structured interview
includes algorithms from the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) in children and
adolescents [37]. The child will also be screened for aut-
ism with the two Social Communication Questionnaires
(SCQ) completed by the parents. The child will be
excluded from the trial if there is a cut-off score above
15 on both the SCQ questionnaires [38]. The parents
also complete the Adult Self-Report Scale (ASRS), which
is a screening for adult ADHD symptoms [39]. The
child’s teachers will be asked to complete the Strength
and Difficulties Questionnaire (SDQ) [40]. The child
will be tested with the Children Attachment Interview
(CAI) [41] before any medical treatment is initiated.
The children who have not been assessed by the Wechs-
ler Intelligence Scale for Children (Wisc-3 test) during
the last 3 years will be tested with the Wisc-3 test by
psychologists from the Clinic [42].
We estimate that 20 children will be assessed per
treatment program (four identical programs are sched-
uled). This is the number that we believe is needed to
produce approximately 12 to 16 participants for
randomisation.
Outcome measures
All outcomes will be assessed before the interventions
starts and at 3 months and 6 months after randomisa-
tion. The primary outcome measure is an assessment of
ADHD core symptoms. The secondary outcome mea-
sures are an assessment of the children’s social skills.
The tertiary outcomes are an assessment of the attach-
ment between the child and the parents and an assess-
ment of the parents own ADHD symptoms (Table 2).
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￿ CAI [41]. The CAI focuses on the child’s experiences
of his/her own present relevant relations and measures
the child’s view of his/her attachment figures’ accessibil-
ity and sensitivity through the exploration of the inner
object representations. The test consists of 19 questions
that ask the child to recall experiences with his/her
important attachment figures, especially at times where
the child has been sad, anxious, or ill. The interview will
be video recorded, and a scoring weight will be attached
both to verbal and nonverbal statements. The test can
assign the children to 1 of 6 possible attachment
Medical 
protocol 
Test phase 
 
Starting with 
Ritalin 
(methylphenidate) as 
the first choice of 
medicine in the test 
phase. 
 
1) 5 mg x 2-3 
2) 10 mg x 2-3 
3) 15 mg x 2-3 
4) 20 mg 2-3 
 
Stabilization 
phase 
 
Along with the parents, a 
depot  preparation 
corresponding to fast-
acting methylpenidate 
in equipotent doses is 
considered.  
 
Second choice 
 
If there is no effect on this 
preparation, 
dexamphetamine is 
tested as second choice in 
the following increase 
(this preparation is not 
given if danger of abuse is 
suspected):  
1) 5 mg x 2 
2) 10 mg x 2 (if no effect 
on 1) 
 
Two-track 
treatment 
When the ADHD 
medicine is tested, an 
observation period of at 
least 8 months will be 
aimed at before a two-
track treatment is decided 
on. (Two-track treatment 
is supplementary 
treatment with e.g. 
neuroleptics, 
antidepressants or 
antiepileptics etc.) 
Third choice 
 
In case of suspicion of 
abuse of dexamphetamine 
or a significant anxiety 
component, change to 
Strattera (atomexetine) 
is considered as third 
choice in the following 
increase: 
1.2 to 1.4 mg per kg per 
day.      
 
Figure 2 Medical protocol.
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Page 5 of 11categories. In this study, the children are given 1 of the
following four attachment categories: secure attachment,
insecure, disorganized/secure, or disorganized/insecure
attachment. This test can be used for children aged 6 to
14 years. (Danish version).
￿ K-SADS clinical diagnostic interview [37]. This
test has been translated into Danish by Dorthe Janne
Petersen and Niels Bilenberg. It is an internationally
known diagnostic interview system, referred as Sche-
dule for Affective Disorders and Schizophrenia for
School-aged Children, Present and Lifetime Version
(K-SADS-PL). The interview is used to diagnose
children aged 6 to 18 years. Using the interview
makes it possible to classify child and youth psychia-
tric diagnoses according to the DSM-III-R and
DSM-IV-systems.
￿ Conners CBRS Teacher [43]. This questionnaire
has been translated into Danish by psychologist Ole
Jakob Storebø and psychologist Kirsten Bach in col-
laboration with Dorte Damm, Per Hove Thomsen,
and the Dansk Psykologisk Forlag. This is an inter-
nationally approved instrument, which is used on
children aged 6 to 18 years. The instrument has
strong psychometrically qualities and measures beha-
viour, school performance, and emotional and social
abilities.
Table 1 Criteria for inclusion and exclusion in the SOSTRA trial
Inclusion: Exclusion:
1) The parents should be interested in taking part in parental
groups in Child Psychiatric Clinic in Holbaek.
Patients with the following diagnoses according to DSM IV:
1) Schizophrenia:
295.30 (Paranoid type); 295.10 (Disorganized type); 295.20
(Catatonic type); 295.90 (Undifferentiated type); 295.60 (Residual
type); 295.70 (Schizoaffective Disorder); 297.1 (Delusional Disorder);
298.8 (Brief Psychotic Disorder); 297.3 (Shared Psychotic Disorder);
298.9 (Psychotic Disorder Not Otherwise Specified).
2) The patients (and the parents) must understand and speak
Danish language to an extent where a translator is not needed in
order to be able to complete the assessment and the treatment.
2) Children with autism according to DSM IV:
299.00 (Autistic Disorder); 299.10 (Childhood Disintegrative
Disorder); 299.80 (Asperger’s Disorder), or a cut of score on both the
SCQ questionnaires above 15.
3) The patients’ parents must give informed consent to participate
in the trial.
3) Violent and criminal youngsters.
4) The child must be between 8 to 12 years old by the time of the
start of the assessment.
4) Children with a total verbal and nonverbal intelligence quotient
below 80 according to WISC III
5) Both boys and girls can participate. 5) Strong resistance from the child against participating.
6) Children with a total verbal or nonverbal intelligence quotient
over 80 according to the WISC III.
6) Previous started medical treatment for ADHD.
7) The children must fulfil research criteria for the diagnosis ADHD
according to DSM IV (1994): 314.00, 314.01, 314.02. or 314.9.
7) Lacking informed consent.
8) The parents must consent in medical treatment for their child
and there must be clinical indication for medical treatment.
Table 2 Outcome measures in the SOSTRA trial
Primary outcome: Measured by:
ADHD symptoms. Conners’ 3
rd Edition subscale ‘hyperactivity-impulsivity’ (teacher rated).
Secondary outcomes:
Social skills. Conners’ CBRS subscale ‘social problems’ (teacher rated) and by Conners’ 3
rd Edition
subscale: ‘peer relations’ (teacher rated).
Aggressive behaviour. Conners’ CBRS subscale: ‘aggressive behavior’ (teacher rated).
Emotional distress. Conners’ CBRS subscale: ‘emotional distress’ (teacher rated).
Executive functions. Conners’ 3
rd Edition subscale: ‘executive functioning’ (teacher rated).
Academic performance. Conners’ CBRS: subscale: ‘academic performances’ (teacher rated).
Tertiary outcomes:
Social skills and symptoms of ADHD measured in relation to
attachment.
Children Attachment Interview.
Improvements in the ability to form attachments. Children Attachment Interview.
Social skills and symptoms of ADHD measured in relation to
parental ADHD symptoms.
Adult Self Report Scale Symptom Checklist.
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Page 6 of 11￿ Conners 3
rd Edition Teacher [44]. This question-
naire has been translated into Danish by psycholo-
gist Ole Jakob Storebø and psychologist Kirsten
Bach in collaboration with Dorte Damm, Per Hove
Thomsen, and Dansk Psykologisk Forlag. This is an
internationally approved instrument, which is used
on children aged 6 to 18 years. The instrument has
strong psychometrically qualities and measures
ADHD core symptoms, behaviour, and emotional
and social abilities.
￿ ASRS Symptom Checklist [39]. This question-
naire covers the 18 DSM-IV-TR criteria for ADHD.
It is used on adults. According to the American
background material, 6 of the 18 questions have
been identified as the most predicative of symptoms
in relation to ADHD. These 6 questions form the
basis of the ASRS v1.1 screening instrument and
represents section A of the symptom checklist. Sec-
tion B of the symptom checklist contains the
remaining 12 questions. (Danish version).
￿ SCQ [38]. This is a screening instrument for aut-
ism and autism-spectrum disturbance among chil-
dren aged four years and older, and is filled out by
the parents.
￿ SDQ [40]. This is a brief behavioural questionnaire
for children aged 3 to 16 years, and is filled out by
the teacher.
￿ Wisc 3 [42]. This is a test used to evaluate intelli-
gence and cognitive functions among children aged
6-16 years.
Randomisation
Central randomisation is performed by the Copenhagen
Trial Unit (CTU) with computer generated, permuted ran-
domisation sequence with unknown block size for the
investigators. A research secretary will call the CTU and
providing a personal pin code, patient number, and the
stratification variables of sex (female/male) and comorbid-
ity (yes/no). Then the randomisation will be announced.
Blinding
The interventions are not blinded to participants, par-
ents, treating physicians, or personnel in the clinic.
However, the outcome assessor of the primary and sec-
ondary outcomes is the teacher, who is kept blinded of
the child’s allocated intervention. The involved parties
(the parents and children) are instructed not to inform
the teacher of the allocation. To secure integrity of trial
data, the principal investigator will collect the question-
naires blind to the intervention. Blinded data will be
handed over to the CTU, which will be in charge of
data entry and statistical analyses blinded to interven-
tion. Standardised procedures will be assured.
Sample size
The sample size is calculated on the basis of a type I
error (a)o f5 %a n dat y p eI Ie r r o r( b)o f2 0 % ,t h u sa
power of 80%, and an allocation ratio of 1:1. With a
clinically relevant difference of a score of 4 between
the experimental intervention group and the control
group on the Conners 3
rd Edition Rating Scale ‘hyper-
activity-impulsivity’ sub index (primary outcome) and
an assumed standard deviation of 5 on the same scale
[45,46], a sample size of 26 participants in each group
is needed. This corresponds to a total of 52 partici-
pants to be randomised. In case of missing follow-up
data (>5%), multiple imputations will be conducted
(see below).
Statistical analysis
Intention-to-treat and per-protocol analyses
The statistical analysis of the outcomes will be based on
the ‘intention-to-treat’ principle, i.e. all randomised par-
ticipants will be included in the analysis in the interven-
tion group to which they were randomized, irrespective
of how much of the intervention they have received.
Per-protocol analyses will be conducted secondarily for
the participants who have completed 50% or more of
their randomised intervention.
According to the ICH Harmonised Tripartite Guide-
line, Statistical Principles for Clinical Trials E9 Analysis
of Drug Trials [47], the analyses will primarily be con-
ducted with adjustment for stratification variables and
will secondarily be conducted without adjustment for
stratification variables.
Statistical analysis plan
The analysis of each outcome measure investigates if the
outcome measure changes (increases or decreases) sig-
nificantly over time in one intervention group as com-
pared with the other one. The group coding is
concealed for the statistician. Provided the outcome
measure is a primary or secondary one, it will be investi-
gated to determine if the effect depends on each of the
tertiary outcome measures as measured at entry. If this
is the case, post hoc explorative subgroup analyses
prompted by the result may be conducted.
To deal with the multiplicity problem, the hypotheses
will be ordered into families of hypotheses, and these
families will in turn be ordered into a hierarchy of
families. The general multistage gate keeping procedure
of Dmitrienko et al. (2008) will then be applied [48].
The two-sided significance level will be 0.05. The gate
keeping will be parallel, and the hypotheses will be orga-
nised into the following families:
1. Hypotheses related to the effect on the primary
outcome measure.
2. Hypotheses related to the effect on the secondary
outcome measures.
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outcome measures.
Once none of the null hypotheses in a family are
rejected, the procedure stops and the rest of the null
hypotheses are accepted. However, the raw P-values of
the remaining tests will be calculated and presented as
the results of post hoc analyses for hypothesis generating
purposes.
The complete analysis of each outcome measure is the
same for the primary and secondary outcome measures.
The outcome measures is set to be M (continuous vari-
able), the indicator of intervention to be I (binary cate-
gorical variable), time to be t (a continuous variable (0,
3, or 6 months)), and the tertiary outcome at baseline to
be O3-baseline (it will be dealt with as a nominal vari-
able in this context). The possibility that the value of M
increases between month 3 and 6 is a real one. There-
fore, the full model may not necessarily be a linear
model in t. Consequently, we will include the quadratic
component t2 in the full model. However, the final
choice of model may be tempered by the impression
obtained from the inspection of the marginal mean
values.
The mixed model repeated measures method will be
used. The model statement without the O3-baseline
included will be specified as follows:
M intercept aI bt ct dIt eIt =+ + + + +
22
where a thru e are coefficients in the model. This
model will test if the mean level as well as the linear and
the quadratic effect of time differ significantly between
the two interventions. A sequential hypothesis testing is
used, which is appropriate for polynomial models. Initi-
ally, four types of covariance matrices will be tested: com-
pound symmetric, AR(1), AR(1) with heterogeneous
variances, and unstructured. Using the Akaike and the
Schwartz Bayesian criteria, the best covariance structure
will be chosen. In the analysis of the continuous tertiary
outcome measures (measurements at entry and after 6
months), compound symmetric and unstructured covar-
iance structures will be compared. When the O3-baseline
is included, the full model will be augmented by the
main effect of O3-baseline and interactions between O3-
baseline and previously included components containing
I, the intervention indicator.
Each analysis will be repeated twice for comparison
(see sensitivity analyses). Missing observations imputed
by the multiple imputations (MI) method will be
included the first time, and only ‘complete cases’ will be
included the second time. However, the main analysis
will be a mixed model analysis including all original
values (without any imputed ones included).
The second tertiary outcome measure is an ordinal
variable with four possible categories. The proportional
odds model with the same type of model statement as
explained above will be used. If the assumption of this
model is not fulfilled, various types of ordinal regression
(SPSS version 17) will be attempted and, if this fails, a
multinomial model will be used. If more than 5% of the
values are missing, two analyses will be made, one only
including ‘complete cases’ and the other including MI
values.
Prevention of missing values
The teachers will be personally informed of the ques-
tionnaires by the therapist, who will assess the behaviour
of the children in school. This therapist will inform the
teacher of the importance that every question is
answered in the questionnaires. The teachers will
receive the questionnaire, along with a letter, at entry
and at 3 and 6 months after treatment. In this letter, the
necessity to answer all of the questions will be empha-
sized, and the teachers will be encouraged to call the
principal investigator in case of any queries. The princi-
pal investigator and research secretary will play active
roles in contacting the teachers of the children with
ADHD and ensuring data collection in case the teachers
fail to return the questionnaires. After receiving the
questionnaires, the principal investigator and research
secretary will assess all of the responses. If they find any
questions unanswered, they will contact the teachers
w i t h i n1w e e ko fr e c e i v i n gt h e questionnaires, ensure
that the missing data is completed, and find out why
those questions were left unanswered. A short 1-day
course will be arranged after the final follow-up and
after receiving the final questionnaires for all of the tea-
chers whose students participated in the trial. The tea-
c h e r sw i l lb ei n f o r m e da b o u tt h i sc o u r s eo n c et h e y
receive the questionnaires at the baseline. All children
and their parents will be contacted by the ADHD team
for a long period of time after the end of this treatment,
often as long as several years; therefore, all children and
their parents will be bound to ambulatory settings and
this study.
Types of missing values
Table 2 shows the outcome measures. From the forms
(Connor 3rd Edition or Connor CBRS), the results of
questions are combined algebraically to produce a num-
ber that is treated as the result of a continuous variable
(the outcome measure). In the forms, the answers to the
questions pertaining to the child’s behaviour during the
previous month are ordinal values (not true (0), some-
times true (1), often true (2), practically true all the time
(3)). It is presumed that whether an outcome measure is
reported or not reported due to at least one question
remaining unanswered within a completed form does
not depend on the unobserved value of the outcome
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Page 8 of 11measure. This type of missing outcome measure result is
referred to as a type 1 missing value.
Outcome measure results may also be missing because
the corresponding form was not completed due to drop
out or other causes (type 2 missing value). In this case,
it is not safe to presume that the pattern of missing
values is not related to the unobserved data. The poten-
tial impact of type 2 missing values is explored using a
worst-case analysis (see below).
Statistical analysis of missing values
One approach for dealing with missing values is to use a
mixed model for repeated measures (MMRM) in the
statistical analysis (see statistical analysis). This model
prevents bias only if the missing at random (MAR)
assumption is fulfilled (the pattern of missing values is
related to the observed data only). The results of the
study are those obtained by this method when it is
applicable for the analysis of the data (the outcome
result of the patients follow a normal distribution with
reasonable approximation in each of the 6 groups
formed by the possible treatment by time combinations).
For comparison, the method of MMRM is supplemen-
ted by that of MI using the model variables and addi-
tional variables significantly related to the variables with
missing values and/or the absence of these variables.
The method used is the fully conditional specification
method of SPSS (version 17.0). This is an iterative Mar-
kov chain Monte Carlo method that can be used when
the pattern of missing data is arbitrary (monotone or
non-monotone). The default number of iterations is
used initially and then increased if the Markov chain
has not converged. Prior to the MI, the distributions of
the continuous variables are inspected to see if serious
deviations from the normal distribution that need trans-
formations are present. Constraints are set to restrict
the range of imputed values of continuous variables so
that they are plausible. In total, 10 imputed data sets are
produced.
Sensitivity analyses
Two sensitivity analyses will be performed.
1. Parameter estimates obtained by complete case
analysis, MMRM, and MI followed by MMCM on
the imputed data sets will be compared [49].
2. A worst-case analysis of the effect of type 2 miss-
ing values will be conducted as follows. The group
coded Effect group will be designated the group with
a significant and beneficial effect on the outcome
measure (say it decreases over time) as compared to
the group coded No Effect group. Missing values
will now be imputed as follows: A). Value(s) missing
in the Effect Group: A single value missing is
imputed with an average of the 2 observed values.
Two values missing are both imputed by the third
observed value. Three values missing are all imputed
by the grand mean of the No Effect group. B). Value
(s) missing in the No Effect-group: A missing
6-month value is imputed by the smallest observed
6-month value in the data. A missing baseline value
is imputed by the largest observed baseline value in
the data. A missing 3-month value is imputed by the
average of 0 and 6-month values whether observed
or imputed as explained above. This should mini-
mize the response to intervention based on imputed
values in patients from the Effect group and give a
maximal negative linear response based on imputed
values in patients from the No Effect group given
the constraint that values more extreme than those
observed must never be used.
MI will only be used if the missing values exceed 5%.
Group comparison at entry
To establish if participant characteristics at trial entry
are relatively similar in the 2 intervention groups
(thereby a low risk of selection bias and confounding),
demographic data (sex and age) and other factors that
can be expected to influence the primary outcomes will
be presented in a table of the entry characteristics.
Ethical considerations and regulatory approval
Participants will be informed of the trial in writing and
orally; written informed consent will be obtained from
the participant’s principal caregivers. There are no appar-
ent ethical problems since all participants are offered
standard medical treatment, and standard control treat-
ment in this population, further, there are no known dis-
advantages of social-skills training. Nevertheless, any
adverse events of the intervention will be reported. The
trial has obtained approval by the Regional Ethics Com-
mittee of Zealand (SJ-85) and is registered with the Dan-
ish Data Protection Agency (J. nr.2008-41-2613) and at
ClinicalTrials.gov (NCT00937469).
Discussion
This trial compares the effects of social-skills training
groups supported by parental training plus standard
treatment versus standard treatment alone on the out-
come of core ADHD symptoms of hyperactivity and
impulsivity. A secondary objective is to examine differ-
ences in the effect of the treatment in relation to the
children’s different abilities in forming attachments:
secure, insecure, disorganized/secure, or disorganized/
insecure attachment. The last objective is to examine
differences in the effect of the treatment in relation to
the degree of parents’ symptoms of ADHD.
The results from this trial can greatly benefit children
with ADHD because social-skills training may have
a greater general effect on social and emotional compe-
tencies than medication alone. Additionally, the
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ments and the effect of the social-skills training can
influence both the understanding and the treatment of
the disease. One of the trial’s strengths is that it is
related to very important matters in the development of
comprehensive treatment programs for ADHD children.
Many children with ADHD have serious problems with
peers because of their lack of emotional and social abil-
ities. ADHD children are often lonely, and their social
problems often lead to a vicious circle, which is difficult
to break [16,17].
Other strengths of this trial are the measurement of
attachment styles in children with ADHD and the com-
parison between the effect of the social-skills training
and the attachment competencies. We do not know of
other studies in which children with an ADHD diagno-
sis are tested with the CAI test. Punto et al. stated that
there is a significant connection between disorganised
attachment in early childhood and ADHD symptoms in
the school-age period [34]. This shows the necessity for
more research on the topic. The possible connection
between attachment problems and ADHD is an interest-
ing topic in the ethological discussion. It must also be
assumed that these children need a form of treatment
that focuses on their inability to form relationships and
their social problems. With the SOSTRA trial, we aim
for improved the treatment of children with ADHD.
There is a greater tendency towards pure medical treat-
ment for children with ADHD, which is reprehensible
because children need a more comprehensive treatment.
The experimental intervention in this trial is relatively
short (8 weeks) and is therefore not very costly. This will
allow other child psychiatric units to incorporate social-
skills training for children with ADHD. A limitation of
this trial is the relatively small sample size, which could
make it difficult to draw firm conclusions about the
research questions. However, if successful, it will be indi-
cative of further directions for research on this topic.
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